Literature DB >> 31403683

Association of Cereal, Gluten, and Dietary Fiber Intake With Islet Autoimmunity and Type 1 Diabetes.

Leena Hakola1, Maija E Miettinen1,2, Essi Syrjälä1, Mari Åkerlund1,2, Hanna-Mari Takkinen1,2, Tuuli E Korhonen2, Suvi Ahonen1,2,3, Jorma Ilonen4, Jorma Toppari5,6, Riitta Veijola7,8, Jaakko Nevalainen1, Mikael Knip9,10,11,12, Suvi M Virtanen1,2,3,13.   

Abstract

IMPORTANCE: Dietary proteins, such as gluten, have been suggested as triggers of the disease process in type 1 diabetes (T1D).
OBJECTIVE: To study the associations of cereal, gluten, and dietary fiber intake with the development of islet autoimmunity (IA) and T1D. DESIGN, SETTING, AND PARTICIPANTS: The prospective birth cohort Finnish Type 1 Diabetes Prediction and Prevention Study recruited children with genetic susceptibility to type 1 diabetes from September 1996 to September 2004 from 2 university hospitals in Finland and followed up every 3 to 12 months up to 6 years for diet, islet autoantibodies, and T1D. Altogether 6081 infants (78% of those invited) participated in the study. Dietary data were available for 5714 children (94.0%) and dietary and IA data were available for 5545 children (91.2%), of whom 3762 (68%) had data on islet autoantibodies up to age 6 years. Information on T1D was available for all children. Data were analyzed in 2018 and end point data were updated in 2015. EXPOSURES: Each child's intake of cereals, gluten, and dietary fiber was calculated from repeated 3-day food records up to 6 years. MAIN OUTCOMES AND MEASURES: Islet autoimmunity was defined as repeated positivity for islet cell antibodies and at least 1 biochemical autoantibody of 3 analyzed, or T1D. Data on the diagnosis of T1D were obtained from Finnish Pediatric Diabetes Register.
RESULTS: Of 5545 children (2950 boys [53.2%]), 246 (4.4%) developed IA and of 5714 children (3033 boys [53.1%]), 90 (1.6%) developed T1D during the 6-year follow-up. Based on joint models, the intake of oats (hazard ratio [HR], 1.08; 95% CI, 1.03-1.13), wheat (HR, 1.09; 95% CI, 1.03-1.15), rye (HR, 1.13; 95% CI, 1.03-1.23), gluten-containing cereals (HR, 1.07; 95% CI, 1.03-1.11), gluten without avenin from oats (HR, 2.23; 95% CI, 1.40-3.57), gluten with avenin (HR, 2.06; 95% CI, 1.45-2.92), and dietary fiber (HR, 1.41; 95% CI, 1.10-1.81) was associated with the risk of developing IA (HRs for 1 g/MJ increase in intake). The intake of oats (HR, 1.10; 95% CI, 1.00-1.21) and rye (HR, 1.20; 95% CI, 1.03-1.41) was associated with the risk of developing T1D. After multiple testing correction, the associations with IA remained statistically significant. CONCLUSIONS AND RELEVANCE: A high intake of oats, gluten-containing cereals, gluten, and dietary fiber was associated with an increased risk of IA. Further studies are needed to confirm or rule out the findings and study potential mechanisms.

Entities:  

Year:  2019        PMID: 31403683      PMCID: PMC6692682          DOI: 10.1001/jamapediatrics.2019.2564

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  11 in total

Review 1.  Zonulin as a potential putative biomarker of risk for shared type 1 diabetes and celiac disease autoimmunity.

Authors:  Lauren K Wood Heickman; Mark D DeBoer; Alessio Fasano
Journal:  Diabetes Metab Res Rev       Date:  2020-03-31       Impact factor: 4.876

Review 2.  Type 1 diabetes-early life origins and changing epidemiology.

Authors:  Jill M Norris; Randi K Johnson; Lars C Stene
Journal:  Lancet Diabetes Endocrinol       Date:  2020-01-27       Impact factor: 32.069

3.  Effect of gluten-free diet and antibiotics on murine gut microbiota and immune response to tetanus vaccination.

Authors:  Pernille Kihl; Lukasz Krych; Ling Deng; Lars H Hansen; Karsten Buschard; Søren Skov; Dennis S Nielsen; Axel Kornerup Hansen
Journal:  PLoS One       Date:  2022-04-13       Impact factor: 3.240

4.  Prevalence of coexisting autoimmune thyroidal diseases in coeliac disease is decreasing.

Authors:  Patricia Dominguez Castro; Grace Harkin; Mary Hussey; Brian Christopher; Clifford Kiat; Jun Liong Chin; Valerie Trimble; Deirdre McNamara; Padraic MacMathuna; Brian Egan; Barbara Ryan; David Kevans; Mohamed Abuzakouk; Richard Farrell; Con Feighery; Valerie Byrnes; Nasir Mahmud; Ross McManus
Journal:  United European Gastroenterol J       Date:  2020-01-07       Impact factor: 4.623

5.  Maternal food consumption during late pregnancy and offspring risk of islet autoimmunity and type 1 diabetes.

Authors:  Randi K Johnson; Roy Tamura; Nicole Frank; Ulla Uusitalo; Jimin Yang; Sari Niinistö; Carin Andrén Aronsson; Anette-G Ziegler; William Hagopian; Marian Rewers; Jorma Toppari; Beena Akolkar; Jeffrey Krischer; Suvi M Virtanen; Jill M Norris
Journal:  Diabetologia       Date:  2021-03-30       Impact factor: 10.460

Review 6.  A Triple Threat? The Role of Diet, Nutrition, and the Microbiota in T1D Pathogenesis.

Authors:  Emma E Hamilton-Williams; Graciela L Lorca; Jill M Norris; Jessica L Dunne
Journal:  Front Nutr       Date:  2021-04-01

7.  Enterovirus Infections Are Associated With the Development of Celiac Disease in a Birth Cohort Study.

Authors:  Maarit Oikarinen; Leena Puustinen; Jussi Lehtonen; Leena Hakola; Satu Simell; Jorma Toppari; Jorma Ilonen; Riitta Veijola; Suvi M Virtanen; Mikael Knip; Heikki Hyöty
Journal:  Front Immunol       Date:  2021-02-02       Impact factor: 7.561

Review 8.  Environmental Determinants of Type 1 Diabetes: From Association to Proving Causality.

Authors:  Lauren M Quinn; F Susan Wong; Parth Narendran
Journal:  Front Immunol       Date:  2021-10-01       Impact factor: 7.561

Review 9.  Environmental Triggering of Type 1 Diabetes Autoimmunity.

Authors:  Pamela Houeiss; Sandrine Luce; Christian Boitard
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

10.  Maternal and child gluten intake and association with type 1 diabetes: The Norwegian Mother and Child Cohort Study.

Authors:  Nicolai A Lund-Blix; German Tapia; Karl Mårild; Anne Lise Brantsaeter; Pål R Njølstad; Geir Joner; Torild Skrivarhaug; Ketil Størdal; Lars C Stene
Journal:  PLoS Med       Date:  2020-03-02       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.